Cite
HARVARD Citation
Morcos, P. et al. (2013). Effect of Ritonavir‐Boosted Danoprevir, a Potent Hepatitis C Virus Protease Inhibitor, on QTc Interval in Healthy Subjects: Results from a Thorough QT Study. Drug development research. 74 (5), pp. 306-315. [Online].